Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
80.28
+0.27 (0.34%)
At close: Dec 26, 2025, 4:00 PM EST
80.24
-0.04 (-0.05%)
After-hours: Dec 26, 2025, 7:00 PM EST
Haemonetics Stock Forecast
Stock Price Forecast
The 8 analysts that cover Haemonetics stock have a consensus rating of "Buy" and an average price target of $88.38, which forecasts a 10.09% increase in the stock price over the next year. The lowest target is $74 and the highest is $100.
Price Target: $88.38 (+10.09%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Haemonetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 2 | 2 | 3 | 1 |
| Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 2 | 1 | 1 | 1 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 8 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $75 → $90 | Buy | Maintains | $75 → $90 | +12.11% | Dec 17, 2025 |
| Baird | Baird | Buy Maintains $87 → $99 | Buy | Maintains | $87 → $99 | +23.32% | Dec 15, 2025 |
| Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 15, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $62 → $74 | Hold | Maintains | $62 → $74 | -7.82% | Dec 12, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $77 → $88 | Strong Buy → Hold | Downgrades | $77 → $88 | +9.62% | Dec 11, 2025 |
Financial Forecast
Revenue This Year
1.33B
from 1.36B
Decreased by -2.19%
Revenue Next Year
1.41B
from 1.33B
Increased by 6.01%
EPS This Year
4.96
from 3.31
Increased by 49.93%
EPS Next Year
5.53
from 4.96
Increased by 11.35%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | 1.5B | |
| Avg | 1.3B | 1.4B | |
| Low | 1.3B | 1.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.1% | 12.0% | |
| Avg | -2.2% | 6.0% | |
| Low | -5.6% | 0.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.20 | 5.90 | |
| Avg | 4.96 | 5.53 | |
| Low | 4.75 | 5.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 57.0% | 18.9% | |
| Avg | 49.9% | 11.3% | |
| Low | 43.6% | 4.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.